Citigroup Inc. Boosts Holdings in Cogent Biosciences: A Strategic Investment in the Technology Sector
An Increase in Holdings: Citigroup Inc. Invests More in Cogent Biosciences In the first quarter of this year, Citigroup Inc. ...
Tag: COGT
Citigroup Inc. Boosts Holdings in Cogent Biosciences: A Strategic Investment in the Technology Sector
An Increase in Holdings: Citigroup Inc. Invests More in Cogent Biosciences In the first quarter of this year, Citigroup Inc. ...
Acadian Asset Management LLC Decreases Stake in Oportun Financial Co.: Implications and Outlook
Acadian Asset Management LLC recently announced a significant decrease in its stake in Oportun Financial Co. During the first quarter ...
Cogent Biosciences: Poised for Success in the Biotech Sector
Cogent Biosciences, a biotech company specializing in the development of innovative therapies, has recently received positive ratings from equities analysts. ...
Barclays PLC Sells Off Cogent Biosciences Shares: Research Firms Remain Bullish on Stock
August 22, 2023 - Barclays PLC, a multinational investment bank, recently disclosed a significant reduction in its holdings of Cogent ...
The Changing Ownership Landscape of Cogent Biosciences: Insights and Implications
Cogent Biosciences, Inc. (NASDAQ:COGT) is a technology company that recently caught the attention of investors due to some significant changes ...
Arizona State Retirement System Acquires Stake in Cogent Biosciences: Pioneering Precision Therapies for Genetically Defined Diseases
August 1, 2023 - In a recent filing with the SEC, the Arizona State Retirement System revealed its acquisition of ...
Potential for Growth: A Look into Cogent Biosciences and its Innovative Precision Therapies
As of June 12, 2023, shares of COGT stock opened at $12.01 on Monday with a market cap of $852.11 ...
Piper Sandler Analyst Reaffirms Overweight Rating on Cogent Biosciences
On June 12, 2023, Piper Sandler analyst Christopher Raymond reaffirmed his Overweight rating on Cogent Biosciences (NASDAQ:COGT) and maintained a ...
Swiss National Bank Shows Confidence in Cogent Biosciences’ Clinical Trial Evaluations for Undruggable Diseases
The vast expanse of investment opportunities in the world of commerce often leaves even the most accomplished investors grappling with ...